CR Bard Inc.
730 Central Avenue
Murray Hill,
NJ 07974
Phone: 908-277-8000
Fax: 908-277-8078
Web Site: http://www.crbard.com
| REUTERS ABRIDGED BUSINESS SUMMARY | |
| C. R. Bard, Inc. and its subsidiaries engage in the design, manufacture, packaging, distribution, and sale of medical, surgical, diagnostic, and patient care devices worldwide. It offers vascular, urology, oncology, and surgical specialty products. The company's vascular products include percutaneous transluminal angioplasty catheters, guidewires, introducers and accessories, peripheral stents, stent grafts, vena cava filters, and biopsy devices; electrophysiology products, such as electrophysiology laboratory systems and diagnostic, therapeutic, and temporary pacing electrode catheters; and fabrics, meshes, and implantable vascular grafts. Its urology products comprise Foley catheters; surgical slings used to treat stress urinary incontinence; natural and synthetic devices to treat pelvic floor and vaginal prolapse; brachytherapy services, devices, and radioactive seeds used to treat prostate cancer; urine monitoring and collection systems; ureteral stents; and specialty devices for ureteroscopic procedures and stone removal. The company offers various devices to treat and manage cancers, and other diseases and disorders. Its oncology products include specialty access catheters, ports, vascular access ultrasound devices, and enteral feeding devices. The company's surgical specialty products include patches and fixation systems for hernia and other soft tissue repairs; irrigation devices for orthopaedic, laparoscopic, and gynecological procedures; and products for topical hemostasis. C. R. Bard sells its products directly and through distributors to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. The company was founded in 1907 and is based in Murray Hill, New Jersey. |
|
| Key Statistics | More from Reuters
Expanded Business Description |
| |
| REUTERS ABRIDGED FINANCIAL SUMMARY | |
| | Pay | Exercised | Mr. Timothy M. Ring , 50
Chairman and Chief Exec. Officer |
N/A
| N/A | Mr. John H. Weiland , 52
Pres, Chief Operating Officer |
N/A
| N/A | Mr. Todd C. Schermerhorn , 47
Chief Financial Officer and Sr. VP |
N/A
| N/A | Ms. Amy S. Paul , 56
Group VP of International |
N/A
| N/A | Mr. Brian P. Kelly , 50
Group VP |
N/A
| N/A |
|
|
|
Dollar amounts are as of
and compensation values are for the last fiscal
year ending on that date. "Pay" is salary, bonuses, etc. "Exercised" is the value of
options exercised during the fiscal year.
| |
|
0.60 (0.74%)
Reuters offers more in-depth
